Ken Griffin Twist Bioscience Corp Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Twist Bioscience Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 41,600 shares of TWST stock, worth $1.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,600

Previous 48,300 13.87%

Holding current value

$1.77 Million

Previous $1.66 Million 23.72%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$27.95 - $53.0 $7.96 Million - $15.1 Million	-284,635 Reduced 16.62%	1,427,810 $70.4 Million
Q1 2024 May 15, 2024	SELL	$32.28 - $41.5 $4.11 Million - $5.28 Million	-127,171 Reduced 6.91%	1,712,445 $58.8 Million
Q4 2023 Feb 14, 2024	BUY	$15.08 - $38.61 $4.24 Million - $10.9 Million	281,165 Added 18.04%	1,839,616 $67.8 Million
Q3 2023 Nov 14, 2023	SELL	$18.62 - $26.57 $116,859 - $166,753	-6,276 Reduced 0.4%	1,558,451 $31.6 Million
Q2 2023 Aug 14, 2023	BUY	$11.49 - $20.46 $4.49 Million - $8 Million	390,899 Added 33.3%	1,564,727 $32 Million
Q1 2023 May 15, 2023	BUY	$14.6 - $30.9 $8.89 Million - $18.8 Million	608,802 Added 107.75%	1,173,828 $17.7 Million
Q4 2022 Feb 14, 2023	BUY	$21.92 - $39.37 $10.9 Million - $19.6 Million	497,109 Added 731.94%	565,026 $13.5 Million
Q3 2022 Nov 14, 2022	SELL	$33.44 - $56.56 $13.7 Million - $23.2 Million	-410,309 Reduced 85.8%	67,917 $2.39 Million
Q2 2022 Aug 15, 2022	BUY	$26.2 - $54.0 $7.11 Million - $14.6 Million	271,200 Added 131.0%	478,226 $16.7 Million
Q1 2022 May 16, 2022	BUY	$38.58 - $83.27 $810,411 - $1.75 Million	21,006 Added 11.29%	207,026 $10.2 Million
Q4 2021 Feb 14, 2022	BUY	$75.47 - $135.88 $7.77 Million - $14 Million	103,007 Added 124.09%	186,020 $14.4 Million
Q3 2021 Nov 15, 2021	BUY	$95.64 - $131.48 $7.52 Million - $10.3 Million	78,595 Added 1778.97%	83,013 $8.88 Million
Q2 2021 Aug 16, 2021	BUY	$88.13 - $142.06 $42,302 - $68,188	480 Added 12.19%	4,418 $588,000
Q1 2021 May 17, 2021	SELL	$105.48 - $207.97 $36,179 - $71,333	-343 Reduced 8.01%	3,938 $488,000
Q4 2020 Feb 16, 2021	SELL	$76.64 - $167.89 $941,369 - $2.06 Million	-12,283 Reduced 74.15%	4,281 $605,000
Q3 2020 Nov 16, 2020	SELL	$45.46 - $78.79 $1.88 Million - $3.25 Million	-41,296 Reduced 71.37%	16,564 $1.26 Million
Q2 2020 Aug 14, 2020	BUY	$26.4 - $45.3 $1.53 Million - $2.62 Million	57,860 New	57,860 $2.62 Million
Q1 2020 May 15, 2020	SELL	$19.71 - $35.15 $2.89 Million - $5.16 Million	-146,802 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$21.0 - $26.48 $1.17 Million - $1.47 Million	55,525 Added 60.83%	146,802 $3.08 Million
Q3 2019 Nov 14, 2019	BUY	$23.72 - $33.99 $2.17 Million - $3.1 Million	91,277 New	91,277 $2.18 Million

Others Institutions Holding TWST

# of Institutions

276

Shares Held

66.9M

Call Options Held

209K

Put Options Held

111K

View Full List

About Twist Bioscience Corp

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.4B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

More about TWST

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account